My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2025-126D
CBCC
>
Official Documents
>
2020's
>
2025
>
2025-126D
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/18/2025 10:43:54 AM
Creation date
9/8/2025 1:42:16 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
06/03/2025
Control Number
2025-126D
Agenda Item Number
13.D.1.
Entity Name
Rightway Healthcare, Inc.
Subject
Pharmacy Benefit Management Services Agreement
Document Relationships
2025-126
(Cover Page)
Path:
\Official Documents\2020's\2025
2025-126A
(Cover Page)
Path:
\Official Documents\2020's\2025
2025-126B
(Cover Page)
Path:
\Official Documents\2020's\2025
2025-126C
(Cover Page)
Path:
\Official Documents\2020's\2025
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
179
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Docusign Envelope ID: 921F7A24-D5CE-4BCC-9F3C-5E7844661266 <br />21533070300130 <br />Sutent CAPS 25 MG <br />16.50% <br />16.50% <br />21533070300135 <br />Sutent CAPS 37.5 MG <br />16.50% <br />16.50% <br />21533070300140 <br />Sutent CAPS 50 MG <br />16.50% <br />16.50% <br />21533076250120 <br />Fotivda CAPS 0.89 MG <br />16.00% <br />21533076250130 <br />Fotivda CAPS 1.34 MG <br />16.00% <br />21533085000320 <br />Caprelsa TABS 100 MG <br />14.00% <br />21533085000340 <br />Caprelsa TABS 300 MG <br />14.00% <br />21533565500110 <br />Koselugo CAPS 10 MG <br />14.50% <br />21533565500125 <br />Koselugo CAPS 25 MG <br />14.50% <br />21533570100330 <br />Mekinist TABS 2 MG <br />15.50% <br />21533675200320 <br />Tazverik TABS 200 MG <br />13.00% <br />21533716200320 <br />Tabrecta TABS 150 MG <br />15.75% <br />21533716200330 <br />Tabrecta TABS 200 MG <br />15.75% <br />21533773100320 <br />Tepmetko TABS 225 MG <br />13.00% <br />21533820000130 <br />Rozlytrek CAPS 200 MG <br />16.00% <br />21533835200120 <br />Vitrakvi CAPS 25 MG <br />13.00% <br />21533835200150 <br />Vitrakvi CAPS 100 MG <br />16.25% <br />21533835202020 <br />Vitrakvi SOLN 20 MG/ML <br />13.00% <br />21533865000120 <br />Augtyro CAPS 40 MG <br />13.00% <br />21534940000320 <br />Tibsovo TABS 250 MG <br />13.00% <br />21534960000120 <br />Rezlidhia CAPS 150 MG <br />13.00% <br />21535030200320 <br />IDHIFA TABS 50 MG <br />16.50% <br />21535030200340 <br />IDHIFA TABS 100 MG <br />16.50% <br />21535180000320 <br />Voranigo TABS 10 MG <br />13.00% <br />21535180000340 <br />Voranigo TABS 40 MG <br />13.00% <br />21535325602140 <br />Rytelo SOLR 188 MG <br />13.00% <br />21535550200120 <br />Zejula CAPS 100 MG <br />13.00% <br />21535550200320 <br />Zejula TABS 100 MG <br />13.00% <br />21535550200330 <br />Zejula TABS 200 MG <br />13.00% <br />21535550200340 <br />Zejula TABS 300 MG <br />13.00% <br />21535570200320 <br />Rubraca TABS 200 MG <br />13.00% <br />21535570200325 <br />Rubraca TABS 250 MG <br />13.00% <br />21535570200330 <br />Rubraca TABS 300 MG <br />13.00% <br />21535580400105 <br />Talzenna CAPS 0.1 MG <br />13.00% <br />21535580400110 <br />Talzenna CAPS 0.25 MG <br />16.50% <br />21535580400112 <br />Talzenna CAPS 0.35 MG <br />13.00% <br />21535580400118 <br />Talzenna CAPS 0.75 MG <br />13.00% <br />56 <br />This document is CONFIDENTIAL AND PROPRIETARY to RIGHTWAY Healthcare, Inc. and may not be reproduced, <br />transmitted, published, or disclosed to others without the prior written authorization of RIGHTWAY Healthcare, Inc. <br />
The URL can be used to link to this page
Your browser does not support the video tag.